Explore a comprehensive medical lecture where Dr. Paul Richardson shares expert insights into the evolving landscape of multiple myeloma treatment, highlighting promising developments and future therapeutic directions. Gain valuable clinical perspectives on novel approaches and next-generation therapies that are shaping the future of multiple myeloma care, offering hope and improved outcomes for patients. Throughout this 47-minute presentation, learn about cutting-edge treatment strategies and advances in the field from one of Dana-Farber Cancer Institute's leading specialists.
Future Directions for Novel and Next Generation Therapy in Multiple Myeloma
Dana-Farber Cancer Institute via YouTube
Overview
Syllabus
Future Directions for Novel and Next Generation Therapy in Multiple Myeloma | Dana-Farber
Taught by
Dana-Farber Cancer Institute
Related Courses
-
Future of Novel Next-Generation Therapy in the Management of Relapsed/Refractory Multiple Myeloma
-
Bispecific Antibodies in Multiple Myeloma
-
The Evolution of Systemic Therapy for Newly Diagnosed Multiple Myeloma
-
Updates in Managing Bone Disease in Multiple Myeloma
-
Continued Evolution of Therapy for Patients with Newly Diagnosed Multiple Myeloma
-
Bispecific Antibody Therapy for Treating Relapsed and Refractory Multiple Myeloma
